The common cold is a contagious viral infection that affects millions of people each year. It is the leading cause of lost work and school days, and can cause a wide range of symptoms from a sore throat and runny nose to body aches and fatigue. Fortunately, there are a variety of treatments available to help alleviate the symptoms of the common cold. One of the most popular treatments is Alka-Seltzer Plus Cold, a combination of aspirin, citric acid, and sodium bicarbonate. This medication helps to reduce the severity of common cold symptoms by providing relief from fever, sore throat, and other discomforts. In this article, we will discuss how Alka-Seltzer Plus Cold can help you beat the common cold.
Alka-Seltzer Plus Cold is a combination of aspirin, citric acid, and sodium bicarbonate. Aspirin is a pain reliever and fever reducer, while citric acid and sodium bicarbonate are antacids that help to relieve heartburn and indigestion. The combination of these three ingredients helps to reduce the severity of common cold symptoms, such as fever, sore throat, and body aches. Alka-Seltzer Plus Cold is available in both tablet and liquid form, and is safe for adults and children over the age of 12.
Alka-Seltzer Plus Cold works by relieving the symptoms of the common cold. Aspirin helps to reduce fever and relieve pain, while the antacid ingredients help to reduce heartburn and indigestion. In addition, the sodium bicarbonate helps to reduce the amount of mucus in the throat and nose, which can help to reduce congestion and breathing difficulties.
Alka-Seltzer Plus Cold is beneficial for those suffering from the common cold because it can provide fast relief from a variety of symptoms. The combination of aspirin and antacid ingredients helps to reduce fever, sore throat, and body aches. In addition, the sodium bicarbonate helps to reduce the amount of mucus in the throat and nose, which can help to reduce congestion and breathing difficulties.
Although Alka-Seltzer Plus Cold is generally safe to use, it can cause some side effects. The most common side effects include nausea, vomiting, stomach pain, and diarrhea. In addition, those who are allergic to aspirin should not take Alka-Seltzer Plus Cold, as it can cause an allergic reaction.
Alka-Seltzer Plus Cold is an effective treatment for the common cold, providing fast relief from fever, sore throat, and other discomforts. The combination of aspirin, citric acid, and sodium bicarbonate helps to reduce the severity of common cold symptoms, and is safe for adults and children over the age of 12. However, if you are experiencing severe symptoms of the common cold, it is important to seek medical attention.
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation